Clinical Trials Browser

Phase 2 × Gastric Adenocarcinoma × XELOX × Clear all

NCT06196697 2024-06-27

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Phase 2 Recruiting

Gastrointestinal

Gastric Adenocarcinoma